Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-deamino-8-d-arginine Vasopressin
2. 1-desamino-8-arginine Vasopressin
3. Acetate, Desmopressin
4. Adiuretin
5. Adiuretin Sd
6. Apo-desmopressin
7. Arginine Vasopressin, Deamino
8. Ddavp
9. Deamino Arginine Vasopressin
10. Desmogalen
11. Desmopressin
12. Desmopressin Monoacetate
13. Desmopressin Monoacetate, Trihydrate
14. Desmopressine Ferring
15. Desmospray
16. Desmotabs
17. Ferring, Desmopressine
18. Minirin
19. Minurin
20. Monoacetate, Desmopressin
21. Monoacetate, Trihydrate Desmopressin
22. Nocutil
23. Octim
24. Octostim
25. Trihydrate Desmopressin Monoacetate
26. Vasopressin, 1-deamino-8-d-arginine
27. Vasopressin, 1-desamino-8-arginine
28. Vasopressin, Deamino Arginine
1. Octostim
2. Minirin
3. Ddavp
4. Stimate
5. Concentraid
6. Desmopressin Acetate Anhydrous
7. Noctiva
8. 62288-83-9
9. Ddavp (needs No Refrigeration)
10. Desmospray
11. Anhydrous Desmopressin Acetate
12. Desmopressin Acetate Preservative Free
13. Desmopressin Acetate (needs No Refrigeration)
14. 1k12647sfc
15. Desmopressin Acetate Hydrate
16. Desmotabs
17. Minirine
18. Nocutil
19. Octim
20. Desmopressin Acetate Trihydrate
21. Demopressin Acetate
22. Ddavp Nasal Spray
23. Ddavp Rhinal Tube
24. Stimate Nasal Spray
25. Noqdirna
26. Presinex
27. Desmomelt
28. Unii-1k12647sfc
29. Desmopressin Acetate [usan:jan]
30. Chembl1200556
31. Dtxsid4046864
32. 16679-58-6(free Base)
33. Desmopressin Acetate [mi]
34. Stimate (needs No Refrigeration)
35. Ex-a4285
36. 1-(3-mercaptopropionic Acid)-8-d-arginine Vasopression Monoacetate
37. Bdbm50247923
38. Mfcd00133962
39. Akos025311518
40. Ccg-270644
41. Desmopressin Monoacetate Anhydrous
42. Anhydrous Desmopressin Acetate [mart.]
43. (deamino-cys1,d-arg8)-vasopressin Acetate
44. 789d983
45. Q27252517
46. 1-(3-mercaptopropionic Acid)-8-d-arginine-vasopressin Monoacetate (salt)
47. Vasopressin, 1-(3-mercaptopropanoic Acid)-8-d-arginine-, Monoacetate (salt)
48. Vasopressin,1-(3-mercaptopropanoic Acid)-8-d-arginine-,monoacetate(salt)(9ci)
Molecular Weight | 1129.3 g/mol |
---|---|
Molecular Formula | C48H68N14O14S2 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 17 |
Rotatable Bond Count | 19 |
Exact Mass | 1128.44808525 g/mol |
Monoisotopic Mass | 1128.44808525 g/mol |
Topological Polar Surface Area | 526 Ų |
Heavy Atom Count | 78 |
Formal Charge | 0 |
Complexity | 2070 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Desmopressin acetate |
Drug Label | Desmopressin Nasal Spray Solution USP, 0.01% is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. The structural formula for the active ingredient is:Mol. w... |
Active Ingredient | Desmopressin acetate |
Dosage Form | Injectable; Spray, metered; Tablet; Solution |
Route | Nasal; oral; Injection; Oral |
Strength | 0.01mg/spray; 0.004mg/ml; 0.2mg; 0.01%; 0.1mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Glenmark Generics; Teva Pharms; Hospira; Actavis Labs Fl; Apotex; Bausch And Lomb; Sun Pharm Inds; Teva Pharms Usa; Ferring |
2 of 2 | |
---|---|
Drug Name | Desmopressin acetate |
Drug Label | Desmopressin Nasal Spray Solution USP, 0.01% is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation. The structural formula for the active ingredient is:Mol. w... |
Active Ingredient | Desmopressin acetate |
Dosage Form | Injectable; Spray, metered; Tablet; Solution |
Route | Nasal; oral; Injection; Oral |
Strength | 0.01mg/spray; 0.004mg/ml; 0.2mg; 0.01%; 0.1mg |
Market Status | Tentative Approval; Prescription |
Company | Mylan Pharms; Glenmark Generics; Teva Pharms; Hospira; Actavis Labs Fl; Apotex; Bausch And Lomb; Sun Pharm Inds; Teva Pharms Usa; Ferring |
Antidiuretic Agents
Agents that reduce the excretion of URINE, most notably the octapeptide VASOPRESSINS. (See all compounds classified as Antidiuretic Agents.)
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Desmopressin Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Desmopressin Acetate manufacturer or Desmopressin Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Desmopressin Acetate manufacturer or Desmopressin Acetate supplier.
PharmaCompass also assists you with knowing the Desmopressin Acetate API Price utilized in the formulation of products. Desmopressin Acetate API Price is not always fixed or binding as the Desmopressin Acetate Price is obtained through a variety of data sources. The Desmopressin Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Stimate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Stimate, including repackagers and relabelers. The FDA regulates Stimate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Stimate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Stimate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Stimate supplier is an individual or a company that provides Stimate active pharmaceutical ingredient (API) or Stimate finished formulations upon request. The Stimate suppliers may include Stimate API manufacturers, exporters, distributors and traders.
click here to find a list of Stimate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Stimate DMF (Drug Master File) is a document detailing the whole manufacturing process of Stimate active pharmaceutical ingredient (API) in detail. Different forms of Stimate DMFs exist exist since differing nations have different regulations, such as Stimate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Stimate DMF submitted to regulatory agencies in the US is known as a USDMF. Stimate USDMF includes data on Stimate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Stimate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Stimate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Stimate Drug Master File in Japan (Stimate JDMF) empowers Stimate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Stimate JDMF during the approval evaluation for pharmaceutical products. At the time of Stimate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Stimate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Stimate Drug Master File in Korea (Stimate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Stimate. The MFDS reviews the Stimate KDMF as part of the drug registration process and uses the information provided in the Stimate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Stimate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Stimate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Stimate suppliers with KDMF on PharmaCompass.
A Stimate CEP of the European Pharmacopoeia monograph is often referred to as a Stimate Certificate of Suitability (COS). The purpose of a Stimate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Stimate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Stimate to their clients by showing that a Stimate CEP has been issued for it. The manufacturer submits a Stimate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Stimate CEP holder for the record. Additionally, the data presented in the Stimate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Stimate DMF.
A Stimate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Stimate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Stimate suppliers with CEP (COS) on PharmaCompass.
A Stimate written confirmation (Stimate WC) is an official document issued by a regulatory agency to a Stimate manufacturer, verifying that the manufacturing facility of a Stimate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Stimate APIs or Stimate finished pharmaceutical products to another nation, regulatory agencies frequently require a Stimate WC (written confirmation) as part of the regulatory process.
click here to find a list of Stimate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Stimate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Stimate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Stimate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Stimate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Stimate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Stimate suppliers with NDC on PharmaCompass.
Stimate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Stimate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Stimate GMP manufacturer or Stimate GMP API supplier for your needs.
A Stimate CoA (Certificate of Analysis) is a formal document that attests to Stimate's compliance with Stimate specifications and serves as a tool for batch-level quality control.
Stimate CoA mostly includes findings from lab analyses of a specific batch. For each Stimate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Stimate may be tested according to a variety of international standards, such as European Pharmacopoeia (Stimate EP), Stimate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Stimate USP).